PharmStar Pharmaceuticals, Inc. (formerly known as Big Star Media Group) (PINKSHEETS: BMGI), which is focused on the manufacturing and marketing of the FDA-approved, Over-the-Counter (OTC) liquid pain reliever Aquaprin™, announced today the appointment of Howard Phykitt as Chairman of the Board of Directors and Chief Executive Officer of the Company.
Having spent the past 17 years researching, testing, patenting and developing Aquaprin, Mr. Phykitt is now ready to bring his most important work to the $30 billion pain management industry. In the 1970s, Mr. Phykitt developed a unique granulation and coating technology that is used today by Eli Lily, Glaxo Smithkline and others in the manufacturing of a litany of pharmaceutical products. In 1984, Mr. Phykitt founded Granutec, Inc., where he developed fluid bed micro-encapsulation for use in the pharmaceutical and agriculture industries. By 1988, Granutec grew to $6 million in sales, and rose to over $60 million in sales to companies such as Walmart, Eckerd, Perry Drug, and Rite Aid by 1993.
No comments:
Post a Comment